Form D · Pharmaceuticals
1219014 B.C. Ltd.
Vancouver, A1 · CIK 0001802848
Offering snapshot reported Feb 13, 2020 · SEC filing
- Reported sold
- $30K Offering amount: $30K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 21, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 13, 2020 | Initial | $30,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-360436
Source: Form D, filed Feb 13, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bradley Miles | Executive |
| Cidnee Vaykovich | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1030 West Georgia Street Suite 907
Vancouver, A1, V6E 2Y3
Vancouver, A1, V6E 2Y3